AVAC applauds the appointment of Mark Dybul as Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria. His return to the Global Fund comes at a pivotal moment for global health, ...

AVAC and Access Bridge today issued a global call to action urging governments, donors, manufacturers, implementers, and advocates to work toward a bold but achievable goal: reaching at least three ...

For nearly two years, the US Administration has ignored Congress and denied women and couples of life-saving sexual and reproductive health commodities. So this week’s breaking news that the US ...

Following the first anniversary of the Trump administration’s America First Global Health Strategy, Devex introduces the officials working behind the scenes to turn the strategy into reality. AVAC’s ...

US Government’s Opportunity to Reach At Least Three Million with LEN by 2027 AVAC’s new publication, Now What with Injectable LEN for PrEP: How to Translate Ambition into Accelerated Delivery and ...

The need for PrEP amongst key populations (KPs) is high yet KPs remain underserved in many PrEP programs. To help address this need, Global Black Gay Men Connect, Access Bridge, and AVAC, alongside ...

Seventeen countries are hosting sites for the Phase III efficacy trials of a monthly PrEP pill, called MK-8527, now known as alimatravir, being developed by Merck (also known as MSD outside of the US ...

The term autonomous means that a person can make his or her own decisions about what to do and what to agree to. Researchers must respect that individuals should make their own informed decisions ...

AVAC is an international non-profit organization that leverages its independent voice and global partnerships to accelerate ethical development and equitable delivery of effective HIV prevention ...

In support of Dr. Anthony Fauci, AVAC submitted a letter to the Committee on Homeland Security and Governmental Affairs ahead of a Congressional hearing focused on the origins of COVID-19. This letter ...

The 2026 US HIV Cure Academy brought skilled advocates and leading HIV cure researchers together for three days of learning and engagement. “We may not have a cure, but one thing is sure, we have the ...